2 results
Approved WMOPending
Primary:• To demonstrate the therapeutic equivalence of ONS-3010 (adalimumab biosimilar) compared toHumira® (adalimumab) in patients with plaque psoriasis Secondary:• To assess the safety, tolerability, and immunogenicity of ONS-3010 compared to…
Approved WMORecruiting
The study aim is to examine different doses of Naronapride film-coated tablets (for oral intake) versus placebo in patients with idiopathic or diabetic gastroparesis. In previous clinical trials, Naronapride has been administered to more than 900…